, 2008). The resulting library was predominantly full-length, in-frame clones and had an expressed diversity of > 1012 proteins spread over 17 residues in the BC and FG loops (Figure 1A). Using this library, two selections were performed—one targeting Gephyrin and one targeting PSD-95 (Figure 1B). In each case, the target
protein was immobilized on a solid support and used to purify functional library members via affinity chromatography. The purified mRNA-protein fusions were then amplified to provide a new library learn more enriched for binders to the targets, which was used for the next round of selection. After six rounds, the number of PCR cycles needed to generate the enriched pool decreased markedly, indicating that both selections had converged to predominantly functional clones. A radioactive pull-down assay confirmed this observation Navitoclax ic50 (Figures 1C and 1D), demonstrating that 42% of the Gephyrin FingR pool (round 7) and 45% of the PSD-95 FingR pool (round 6) bound to target with very low background binding. Importantly, cloning and sequencing of each pool indicated that both contained numerous, independent, functional FingRs. Since numerous independent FingRs bound to target, we wished to choose proteins that gave the best intracellular labeling. To do this, we devised a stringent COS
cell screen, wherein the target (e.g., Gephyrin) was localized to the cytoplasmic face of the Golgi apparatus the by appending a short Golgi-targeting sequence (GTS) (Andersson et al., 1997) (Figure 1E). Functional FingRs (“winners”) were defined as those that showed tight subcellular colocalization between the rhodamine-labeled target and the GFP-labeled FingR (Figures 1F–1H). Suboptimal sequences (Figure 1I, “losers”) result in diffuse staining (Figure 1K), poor expression, and/or poor colocalization (Figures 1J and 1L). This experiment allowed us to choose FingR proteins that satisfied three essential
criteria: (1) good expression and folding inside a mammalian cell, (2) lack of aggregation, and (3) high-affinity binding to the intended target under cellular conditions and despite the high levels of other proteins present. Our results confirm the importance and stringency of the screen, as only 10%–20% of FingR clones (4/30 PSD-95 FingRs and 3/14 Gephyrin FingRs) that bind to the target in vitro colocalized with target intracellularly. For determining whether FingRs can label endogenous Gephyrin or PSD-95 in native cells, GFP-tagged FingR cDNAs that were positive in the COS cell assay were expressed in dissociated cortical neurons in culture. After incubation for 14 hr, the cultures were fixed and immunostained for both GFP and the endogenous target proteins. In each selection, at least one FingR (PSD95.FingR for PSD-95, GPHN.FingR for Gephyrin) localized in a punctate manner characteristic of both target proteins (Figures 2A and 2D).